Key takeaways:
Wegovy is an effective weight-loss treatment for many people. Before deciding if it’s right for you, it’s important to be aware of some of the possible side effects of this medication.
Long-term side effects of Wegovy can include gallbladder and pancreas problems, stomach paralysis, vision problems, and possibly bone loss. Many of these conditions are rare, and research is still evolving.
Early studies raised concerns about rare but serious health risks with Wegovy, like thyroid cancer and suicidal thoughts. But follow-up research hasn’t shown these risks.
Save on related medications
Medications like Wegovy have helped a lot of people reach their weight-loss goals. But like with all medications, there are potential risks.
Many people are familiar with some of the mild digestive side effects that improve over time — like nausea, diarrhea, and low blood sugar. But Wegovy can also cause rare long-term complications.
As millions more people have taken Wegovy since its approval, researchers have learned much more about its long-term risks and continue to study them.
Here, we’ll take a closer look at 10 long-term side effects of Wegovy.
1. Gallbladder problems
Wegovy can lead to problems with your gallbladder and bile duct system. The gallbladder is an organ near your liver. It stores bile, a yellowish liquid that helps digest fats. When you eat, the gallbladder releases bile through a duct system that connects to your intestine. This helps you break down and absorb fat from your diet.
Wegovy can increase the risk of gallstones and inflammation of your gallbladder. This could be related to the weight loss from taking Wegovy. That’s because when people lose a lot of weight (or lose weight quickly), they’re at higher risk of experiencing gallbladder issues. But it’s possible that the medication itself may also increase the risk on its own.
Gallbladder issues like inflammation and gallstones can cause blockages in your bile duct system. The symptoms of gallbladder problems include:
Abdominal pain
Fever
Nausea
Vomiting
In the short term, these issues can be treated. But more severe cases may require surgery to remove gallstones or your gallbladder. And any surgery can increase your risk for longer-term health complications. So it’s important to be aware of this risk.
But these side effects are rare. Less than 2% of adults taking Wegovy developed gallstone problems in clinical trials.
2. Pancreatitis
Pancreatitis, or inflammation of the pancreas, is another rare but serious side effect of Wegovy seen in clinical trials.
The pancreas is another digestive organ near the gallbladder. It releases enzymes and hormones that help regulate metabolism and digestion. If the pancreas becomes inflamed, it can cause intense abdominal pain and frequent vomiting.
Like the gallbladder problems mentioned above, these pancreas issues can be treated. But they can also lead to long-term complications in more severe cases.
Earlier studies raised concerns that Wegovy might increase the risk of pancreatitis. But larger studies and more recent reviews haven’t found a clear increase in pancreatitis risk. Because pancreatitis has been reported in people taking Wegovy, healthcare professionals still recommend stopping the medication and seeking medical care if symptoms develop.
It’s not clear whether having a history of pancreatitis increases your risk of being diagnosed with pancreatitis while taking Wegovy. And pancreatitis can’t always be prevented. But limiting or avoiding alcohol will lower your risk.
3. Stomach paralysis
One of the ways that Wegovy helps with weight loss is by slowing down stomach emptying. This helps you feel full after eating smaller amounts of food. But in some cases, people taking Wegovy and similar medications have developed stomach paralysis (also known as gastroparesis).
With gastroparesis, food and liquids move through your stomach more slowly than they should. As a result, the stomach contents may remain in your stomach for a prolonged period of time.
This can lead to:
Nausea
Vomiting
Abdominal pain
Bloating
Uncomfortable feelings of fullness
Gastroparesis wasn’t noted in the initial clinical trials of Wegovy. But as more people have taken Wegovy, a few cases have been reported. And some studies have found a potential link. In some cases, gastroparesis went away when the medication was stopped, but not always.
Certain situations and health conditions can increase your risk for gastroparesis. Be careful taking Wegovy if any of the following apply to you:
You have diabetes.
You’re taking medications that slow down your digestive system, like opioids.
You’ve had stomach surgery in the past.
You have certain nervous system conditions, like multiple sclerosis or Parkinson’s disease.
4. Blocked intestines
Wegovy may lead to another serious digestive complication called a bowel obstruction or blocked intestines. This happens when food gets stuck in your intestine and creates a blockage that prevents intestinal contents from moving in the right direction.
Bowel obstruction can cause intense abdominal pain, nausea, and vomiting. Similar to the side effects above, this complication is rare. But it’s a serious condition that requires emergency care and even surgery.
5. Kidney problems
Some people have experienced sudden (acute) kidney injury while taking Wegovy. Here’s why.
Common Wegovy side effects, like nausea, vomiting, and diarrhea, can all lead to dehydration. And more severe cases of dehydration can affect your kidneys. With severe dehydration, your kidneys don’t receive enough blood flow. This causes kidneys to not function as well as the body needs them to. But this kind of kidney injury is usually reversible. That means it gets better once someone is rehydrated.
Your medical care team may recommend monitoring your kidney function while you take Wegovy if you:
Have underlying kidney problems
Experience severe gastrointestinal side effects that could make you dehydrated
6. Bone loss
Research suggests that people taking Wegovy may experience small decreases in bone mineral density (BMD), especially in weight-bearing bones like the hips and spine. Much of this bone loss appears to be related to the weight loss itself rather than a direct effect of the medication on your bones.
Importantly, studies haven’t consistently linked Wegovy to an increased risk of broken bones (fractures).
There aren’t a lot of studies yet that look at bone loss over time in people taking Wegovy long-term. This will change as more people take this medication over longer periods of time.
Still, it’s important to be aware of this possible risk and discuss it with your healthcare team — especially if you already have a higher-than-average risk of bone loss, including if you:
Are a woman after menopause
Have osteoporosis or osteopenia
Have had a previous fracture from a minor fall
Take medications that weaken bones, such as long-term corticosteroids
Healthcare professionals may recommend regular weight-bearing and resistance exercise, along with getting enough calcium and vitamin D. They may also suggest a bone density (DXA) scan. Since early osteoporosis usually doesn’t cause symptoms until a fracture occurs, screening can help identify bone loss early.
7. Muscle loss
When people lose a significant amount of weight with Wegovy, they can lose a significant amount of muscle along with fat. This isn’t unique to Wegovy — it happens with most rapid or substantial weight loss. Because Wegovy also reduces appetite, some people may also have trouble getting enough protein, which can make muscle loss worse.
Muscle loss can affect your health as you age, including your strength, balance, and mobility. It can also affect your bone health metabolism. But there are ways to help preserve muscle mass while taking Wegovy:
Make sure you eat enough protein throughout your day
Get regular, moderate-intensity physical activity
Do regular strength (resistance) training
8. Hair loss
Hair loss has been reported by 3% of people taking Wegovy. That’s compared to 1% of people taking a placebo in clinical trials. But it seems to be more rare in follow-up studies.
Experts think the hair loss is more likely related to rapid weight loss and reduced calorie intake than to semaglutide itself. Rapid weight loss, including after weight-loss surgery, is also known to cause hair loss.
The type of hair loss caused by Wegovy is known as telogen effluvium, or stress-related hair loss. If you do experience hair loss while taking Wegovy, the effect is usually temporary. Getting enough protein and nutrition in your diet may help prevent hair loss and support regrowth while taking Wegovy.
9. Increased heart rate
People taking Wegovy in clinical trials had small increases in their heart rate. On average, their heart rates increased by 1 to 4 beats per minute. But some people had even greater increases.
For many people, this may not be a problem (or noticeable). But increased heart rate can be a bigger deal for people with certain heart conditions, like atrial fibrillation or heart failure.
If you notice skipped heartbeats, heart palpitations, or a racing heartbeat at rest while taking Wegovy, it’s a good idea to discuss this with your healthcare team. If your heart rate is consistently increased while taking Wegovy, you may need to stop taking the medication.
10. Serious eye problems
Semaglutide has been linked to three different eye conditions, all of which can lead to serious vision impairment:
Diabetic retinopathy
Macular degeneration
A rare type of eye stroke called non-arteritic anterior ischemic optic neuropathy (NAION)
These risks can sound scary, so let’s take a closer look at what the research shows.
Diabetic retinopathy
In people who have diabetes, taking Wegovy may increase the risk of developing diabetic retinopathy. This condition affects the blood vessels in the back of your eye and can lead to vision loss.
The active ingredient in Wegovy, semaglutide, is also used to treat high blood sugar in people with diabetes. It sounds contrary, but a rapid improvement in blood sugar can temporarily worsen diabetic retinopathy.
But the potential benefit may outweigh the risk. The newest research suggests that semaglutide actually improved diabetic eye disease in 60% of people with the condition who took the medication. So researchers are actively studying this issue to provide more answers.
Macular degeneration
A recent study from Canada showed that people with diabetes who took glucagon-like peptide-1 (GLP-1) medications like semaglutide, were twice as likely to develop a specific type of macular degeneration.
This condition can cause small blood vessels in your eye to bleed. But this was still a rare side effect overall: About 2 in every 1,000 people were affected.
Anterior ischemic optic neuropathy
When semaglutide first hit the market, researchers noted a small increase in this rare eye condition. Non-arteritic anterior ischemic optic neuropathy (NAION) is a long name, but it can be thought of as a small stroke in the eye.
NAION occurs when there’s reduced blood flow to certain parts of the eye. In some cases, it can lead to blindness in the affected eye.
Like the other eye conditions above, researchers are trying to better understand this risk. In a large study published in 2025, researchers found that people with diabetes who took semaglutide had a 1.3 times higher risk of NAION. But it’s still very rare, affecting about 1 in every 10,000 people each year.
Is Wegovy safe?
Overall, Wegovy and other semaglutide medications are regarded as safe.
After reading through this list of the potential long-term side effects of Wegovy, it can feel like the risks outweigh the benefits. But keep in mind that most of these side effects are rare. For most people, the health benefits of Wegovy outweigh the risks.
Wegovy can help with more than just weight loss. It also has benefits for things like heart health and stroke prevention.
If you’re at higher risk for any of the long-term side effects above, this doesn’t mean you shouldn’t take Wegovy. Talk to a healthcare professional you know and trust, like your primary care provider. They can help you understand your risk so you can make a decision that feels safe to you.
Frequently asked questions
For most people, the benefits of Wegovy outweigh the risks. But you shouldn’t take Wegovy if you:
Have a personal or family history of medullary thyroid carcinoma (MTC)
Have multiple endocrine neoplasia syndrome type 2 (MEN 2)
Have had a serious allergic reaction to semaglutide or any of Wegovy’s ingredients
Are pregnant or planning to become pregnant
You may also need closer monitoring or a different treatment if you have a history of:
Pancreatitis
Severe gastroparesis
Significant kidney disease
Diabetic retinopathy
Osteoporosis (or you’re at high risk for it)
Your healthcare team can help you decide whether it’s a safe option based on your medical history.
Although semaglutide causes thyroid C-cell tumors in rodents, studies in humans haven’t shown a clear increase in thyroid cancer risk. Because uncertainty remains, Wegovy still carries an FDA black box warning.
The makers of Wegovy still say that certain groups of people at high risk of thyroid tumors should avoid taking Wegovy. These include people with:
Personal or family history of medullary cell carcinoma of the thyroid
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Regaining some weight is common after stopping the medication. A clinical trial showed that after a year, people had gained about two-thirds of the amount of weight they’d lost with the medication. If you do plan to stop taking it, experts suggest tapering the dose before stopping, if possible.
Wegovy and Ozempic are brand names for the same medication: semaglutide. The FDA has approved Wegovy for weight loss and Ozempic for diabetes treatment. They have different dosages but cause similar side effects.
Yes, people who don’t have a gallbladder can still take Wegovy. While there isn’t much research looking at this, it’s possible this could increase your risk of side effects like diarrhea or stomach upset. But it also means you don’t need to think about the risk of gallstones or gallbladder infections. But bile duct issues can still occur. As with other prescription medications, it’s best to discuss your situation with a healthcare professional.
For most people, the benefits of Wegovy outweigh the risks. But you shouldn’t take Wegovy if you:
Have a personal or family history of medullary thyroid carcinoma (MTC)
Have multiple endocrine neoplasia syndrome type 2 (MEN 2)
Have had a serious allergic reaction to semaglutide or any of Wegovy’s ingredients
Are pregnant or planning to become pregnant
You may also need closer monitoring or a different treatment if you have a history of:
Pancreatitis
Severe gastroparesis
Significant kidney disease
Diabetic retinopathy
Osteoporosis (or you’re at high risk for it)
Your healthcare team can help you decide whether it’s a safe option based on your medical history.
Although semaglutide causes thyroid C-cell tumors in rodents, studies in humans haven’t shown a clear increase in thyroid cancer risk. Because uncertainty remains, Wegovy still carries an FDA black box warning.
The makers of Wegovy still say that certain groups of people at high risk of thyroid tumors should avoid taking Wegovy. These include people with:
Personal or family history of medullary cell carcinoma of the thyroid
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Regaining some weight is common after stopping the medication. A clinical trial showed that after a year, people had gained about two-thirds of the amount of weight they’d lost with the medication. If you do plan to stop taking it, experts suggest tapering the dose before stopping, if possible.
Wegovy and Ozempic are brand names for the same medication: semaglutide. The FDA has approved Wegovy for weight loss and Ozempic for diabetes treatment. They have different dosages but cause similar side effects.
Yes, people who don’t have a gallbladder can still take Wegovy. While there isn’t much research looking at this, it’s possible this could increase your risk of side effects like diarrhea or stomach upset. But it also means you don’t need to think about the risk of gallstones or gallbladder infections. But bile duct issues can still occur. As with other prescription medications, it’s best to discuss your situation with a healthcare professional.
The bottom line
Wegovy has powerful benefits for weight loss. But like any medication, it also has potential side effects. Wegovy most commonly causes gastrointestinal problems, and some of these can be serious. Fortunately, the serious side effects seem to be rare.
Because Wegovy and similar medications are still fairly new, there’s a lot experts don’t yet know about long-term effects. The good news is this will change over time. Researchers continue to study Wegovy’s long-term safety as more people use the medication and stay on it for longer.
For now, it’s a good idea to discuss any serious health history or concerning side effects of Wegovy with a healthcare professional.
Why trust our experts?


References
American Academy of Ophthalmology. (2023). Popular weight loss drug does not appear to worsen diabetic eye disease in most patients, new study suggests.
Cai, C. X., et al. (2025). Semaglutide and nonarteritic anterior ischemic optic neuropathy. JAMA Ophthalmology.
ClinicalTrials.gov. (2026). A research study to look at how semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetes (FOCUS).
Feier, C. V. I., et al. (2024). Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (Ozempic) therapy for diabetes mellitus and obesity: A systematic literature review. International Journal of Molecular Sciences.
Jairath, R., et al. (2024). 53028 Semaglutide and hair loss: A real-world analysis. Journal of the American Academy of Dermatology.
Masson, W., et al. (2024). Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis. Endocrinología, Diabetes y Nutrición.
Novo Nordisk Inc. (2026). Wegovy -semaglutide injection [package insert].
Prillaman, M., et al. (2024). What happens when you quit Ozempic and Wegovy? Scientific American.
Shor, R., et al. (2025). Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration. JAMA Ophthalmology.
Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism.
Zhang, W., et al. (2021). Hair loss after metabolic and bariatric surgery: A systematic review and meta-analysis. Obesity Surgery.












